Since the first description of penicillin-resistant pneumococci nearly 30 years ago, drug-resistance has become widespread throughout the world. This review focuses upon the in vitro susceptibility of penicillin-susceptible and -resistant pneumococci to new and existing agents.
No takes yet. Share an insight, caveat, or question.
Peter C. Appelbaum (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: